Literature DB >> 752460

Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin.

H Schaefer, G Stüttgen, A Zesch, W Schalla, J Gazith.   

Abstract

We have measured concentrations of about 30 drugs in the living layers of the skin under conditions which provide data which are applicable in therapeutic treatment. Since the skin is a thin organ and small amounts of drug represent high target concentrations, it is necessary to select a sensitive quantitative method; observation of the kinetics of absorption using radiolabeled drugs is the method of choice. Because of possible hazards--and legal and ethical problems--absorption studies in human skin are commonly performed in vitro. Related in vivo investigations demonstrate the relevance and the limitations of the in vitro experiments. The main hindrance against penetration of drugs is by the horny layer. The barrier-function of this layer--if it is undisturbed--may be described by a multilayer model. The reciprocal function, the reservoir function, is important for the efficiency of topical treatment; it also plays a role in determining the unique pharmacokinetics of drug absorption in the skin and percutaneous resorption. If the horny layer is injured, i.e. in diseased skin, both the barrier and the reservoir functions are disturbed. In consequence, drug concentrations in the skin--and percutaneous resorption--may be greatly enhanced, and topically applied drugs may enter preferentially into diseased areas. The form of application, such as ointment, solution, etc. influences the penetration kinetics in such a specific manner that a specific vehicle for a specific drug should always be postulated. The frequently discussed hazards of side effects due to percutaneous resorption of drugs like corticosteroids are a function of the treated area rather than of its penetration capacity. Thus the indication for local or oral treatment of severe dermatoses should be considered in terms of the affected area. The relatively frequent side effects in the skin itself which originate from unnecessarily high drug concentrations and long term treatment must also be taken into account.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 752460     DOI: 10.1159/000401278

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  9 in total

1.  Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery.

Authors:  D Bommannan; G K Menon; H Okuyama; P M Elias; R H Guy
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

2.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

3.  Modelling dermal drug distribution after topical application in human.

Authors:  Yuri G Anissimov; Michael Stephen Roberts
Journal:  Pharm Res       Date:  2011-04-27       Impact factor: 4.200

4.  In Silico Estimation of Skin Concentration Following the Dermal Exposure to Chemicals.

Authors:  Tomomi Hatanaka; Shun Yoshida; Wesam R Kadhum; Hiroaki Todo; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2015-07-21       Impact factor: 4.200

5.  Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs.

Authors:  J E Riviere; N A Monteiro-Riviere; A O Inman
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

6.  Validation of reflectance infrared spectroscopy as a quantitative method to measure percutaneous absorption in vivo.

Authors:  N Higo; A Naik; D B Bommannan; R O Potts; R H Guy
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

7.  Study of reservoir effect of clobetasol propionate cream in an experimental animal model using histamine-induced wheal suppression test.

Authors:  Afroz Abidi; Farida Ahmad; Satyendra K Singh; Anil Kumar
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

8.  Mathematical model to predict skin concentration after topical application of drugs.

Authors:  Hiroaki Todo; Takeshi Oshizaka; Wesam R Kadhum; Kenji Sugibayashi
Journal:  Pharmaceutics       Date:  2013-12-16       Impact factor: 6.321

9.  Effect of Different Skin Penetration Promoters in Halobetasol Propionate Permeation and Retention in Human Skin.

Authors:  Paulina Carvajal-Vidal; Mireia Mallandrich; María Luisa García; Ana Cristina Calpena
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.